Delgocitinib cream clinical trials

A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

This study is testing a new cream called delgocitinib for adults with palmoplantar pustulosis (PPP), a skin condition causing pus-filled spots on hands and feet. Researchers want to see if the cream is safe and helps improve PPP over 16 weeks.